Masimo (MASI) collaborates with UCHealth to boost patient care by combining its latest virtual care technologies with UCHealth's clinical expertise and telehealth innovations.

Masimo's core segment in Professional Healthcare could have support into a multi-year growth based on current growth of Unrecognized Contract Value growth. Expansion into the consumer space is a lo...

Masimo (MASI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Masimo's (MASI) R&D activities raise optimism about the stock.

Masimo (MASI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Masimo (MASI) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, MASI crossed above the 200-day moving average, suggesting a ...

Bob Chapek, a nearly three-decade Disney veteran who was ousted in 2022 as the media company's CEO, has been appointed to the board of directors of medical tech firm Masimo. The move comes during a...

Masimo's (MASI) fourth-quarter 2023 results are likely to reflect the impacts of the robust adoption of hearable products.

The latest FDA clearance of Masimo's (MASI) Stork smart home baby monitoring system is likely to provide a continuous and accurate view of babies' health data.

Joe Kiani, Masimo CEO, joins 'Closing Bell: Overtime' to discuss Apple pausing some Watch sales due to a patent dispute.

Masimo's (MASI) latest study indicates that ORi can be a valuable tool to provide information on arterial oxygenation even during OLV.

Masimo's (MASI) receipt of the latest FDA approval is expected to provide greater visibility of changes in oxygen saturation to help patients better manage their oxygen levels daily.

Masimo's (MASI) latest joint effort is likely to enable real-time continuous monitoring with a tailored view of the patient's vitals while keeping them mobile during critical recovery periods.

Masimo Corporation (NASDAQ:MASI ) Q3 2023 Earnings Conference Call November 7, 2023 4:30 PM ET Company Participants Eli Kammerman - Vice President, Business Development and Investor Relations Joe K...

Although the revenue and EPS for Masimo (MASI) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall S...